Skip to main content
Back to News
Luminai closed a $38M Series B, bringing total funding to $60M, led by Peak XV. The round supports s...
Funding
1 min read

Luminai closed a $38M Series B, bringing total funding to $60M, led by Peak XV. The round supports s...

The AMW Read

This is a standard Series B funding update for a player in the healthcare vertical AI segment, confirming the continued capital flow into administrative workflow automation.
NoveltySignificance
Healthcare & Bio · Player Map
Luminai
Luminai

AI in Healthcare

View Company Profile

Luminai closed a $38M Series B, bringing total funding to $60M, led by Peak XV. The round supports scaling its AI‑native platform that automates end‑to‑end administrative workflows, a cost center that can consume up to 25% of healthcare spend. With a live deployment at Cleveland Clinic, Luminai’s knowledge‑graph‑driven models translate unstructured data into actionable actions, freeing clinicians for patient care. This capital infusion accelerates AI‑driven efficiency across health systems.

Explore LuminaiRead Original

How This Connects

Based on Healthcare & Bio · Player Map

  1. 1d agoPathos AI raises $237M to scale Foundry and advance four oncology assetsPathos
  2. 2d agoWarp Sciences, founded by former OpenAI science lead Kevin Weil, raises $215M to automate drug-chemistry labsWarp Sciences
  3. 3d agoWarp Sciences raises $215 million for robotic drug-discovery labsWarp Sciences
  4. 1mo agoLevel Five, a game developer, has issued a public apology after facing criticism for what it called...Level Five
  5. 6mo agoLuminai closed a $38M Series B, bringing total funding to $60M, led by Peak XV. The round supports s... · THIS ARTICLE

More news from Luminai

Stay updated with the latest news and announcements from Luminai.

View all Luminai news

Discover AI Startups

Explore 5,000+ AI companies with VC-grade analysis, funding data, and investment insights.

Explore Dashboard